Delivery Order SPE2DB22D3004-SPE2DB25FSA27
- Not listed
- The Defense Logistics Agency awarded a $4,777.92 delivery order to AmerisourceBergen Drug Corp for the supply of Apretude ER 600 mg/3 ml vials. This competitively awarded, non-set-aside contract represents a firm fixed-price delivery order with an ultimate completion date of August 19, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order falls under...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $4,826.26 to Amerisourcebergen Drug Corporation for the supply of 4561960701 APRETUDE ER 600 MG/3 ML VIAL 3ML pharmaceutical products. Performance will occur at Amerisourcebergen's facility located in Conshohocken, Pennsylvania under the contract start and end dates of August 28, 2023 through September 19, 2023. As a major provider of medical supplies and logistics support to the U.S. Department of Defense, this...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,388.96 and is for the delivery of APRETUDE ER 600 MG/3 ML VIAL 3ML, a specialty pharmaceutical product. The contract is a firm fixed-price Delivery Order with a completion date of March 7, 2025. This contract is not designated as a set-aside. AmerisourceBergen holds a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Aponvie 32 mg/4.4 mL vials with a ceiling value of $2,470.69 under a firm fixed price contract. This delivery order represents a non-set-aside, competitively awarded procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for TRUQAP 160 mg tablets (16-count units) valued at $15,959.30, with a firm fixed price structure and an ultimate completion date of August 22, 2025. This non-set-aside competitive award was issued on August 1, 2025, with performance occurring at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 5, 2025, for the supply of Activase 50 mg vials valued at $3,207.38. This non-set-aside, competitively awarded contract features firm fixed pricing and an ultimate completion date of August 6, 2025. The award is funded by the Defense Logistics Agency's Medical Supply Chain, a component of the Department of Defense, and is being performed at the...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,890.46 by the Defense Logistics Agency's Medical Supply Chain on August 2, 2025, with an ultimate completion date of August 4, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. As a child order under a larger vehicle, this award leverages AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop...
- This delivery order, valued at $2,343.59, was awarded to AmerisourceBergen Drug Corp on August 5, 2025, under a Defense Logistics Agency contract with an ultimate completion date of the same day. The order represents a child contract issued against a larger indefinite delivery vehicle and is classified as a firm fixed price, non-set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $4,887.54 to AmerisourceBergen Drug Corp on August 10, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $1 billion pharmaceutical supply vehicle running through December 2026. The delivery order will be fulfilled from the...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $527,598.14 to AmerisourceBergen Drug Corp on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the prime contractor and will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal medical...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FSA27Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,777.92 to AmerisourceBergen Drug Corp for APRETUDE ER 600 mg/3 ml vials on August 15, 2025, with completion targeted for September 8, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside contract with performance to be fulfilled at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award falls under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime contract vehicle extending through December 2026 that provides comprehensive global pharmaceutical support to military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting Defense Health Agency and military healthcare systems. The company maintains an extensive portfolio of pharmaceutical deliveries through DLA, supplying brand-name and generic medications, specialty pharmaceuticals, vaccines, and medical supplies across multiple therapeutic domains. This specific delivery order for APRETUDE exemplifies the company's role in fulfilling specialized pharmaceutical needs for federal healthcare systems through the DLA's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.8k | 8/15/25 |